Literature DB >> 24627089

Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease.

Ilana N Ackerman1, Mark A Tacey, Zanfina Ademi, Megan A Bohensky, Danny Liew, Caroline A Brand.   

Abstract

PURPOSE: To determine whether Assessment of Quality of Life (AQoL) utility scores can be reliably estimated from Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores in people with hip and knee joint disease (arthritis or osteoarthritis).
METHODS: WOMAC and AQoL data were analysed from 219 people recruited for a national population-based study. Generalised linear models were used to estimate AQoL utility scores based on WOMAC total and subscale scores and personal characteristics. Goodness of fit was assessed for each model, and plots of prediction errors versus actual AQoL utility scores were used to gauge bias.
RESULTS: Each model closely predicted the average AQoL utility score for the overall sample (actual mean AQoL 0.64, range of predicted means 0.63-0.64; actual median AQoL 0.71, range of predicted medians 0.68-0.69). No clear preferred model was identified, and overall, the models predicted 40-46% of the variance in AQoL utility scores. The WOMAC function subscale model performed similarly to the total score model. The models functioned best at the mid-range of AQoL scores, with greater bias observed for extreme scores. Inaccuracies in individual-level estimates and low/high health-related quality of life (HRQoL) subgroup estimates were evident.
CONCLUSION: Reliable overall group-level estimates were produced, supporting the application of these techniques at a population level. Using WOMAC scores to predict individual AQoL utility scores is not recommended, and the models may produce inaccurate estimates in studies targeting patients with low/high HRQoL. Where pain and stiffness data are unavailable, the WOMAC function subscale can be used to generate a reasonable utility estimate.

Entities:  

Mesh:

Year:  2014        PMID: 24627089     DOI: 10.1007/s11136-014-0667-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  20 in total

1.  Mapping the Oxford hip score onto the EQ-5D utility index.

Authors:  Rafael A Pinedo-Villanueva; David Turner; Andrew Judge; James P Raftery; Nigel K Arden
Journal:  Qual Life Res       Date:  2012-04-22       Impact factor: 4.147

2.  Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.

Authors:  Graeme Hawthorne; Richard Osborne
Journal:  Aust N Z J Public Health       Date:  2005-04       Impact factor: 2.939

Review 3.  Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL).

Authors:  Lucy Busija; Eva Pausenberger; Terry P Haines; Sharon Haymes; Rachelle Buchbinder; Richard H Osborne
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

4.  Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.

Authors:  Helen Dakin; Alastair Gray; David Murray
Journal:  Qual Life Res       Date:  2012-05-04       Impact factor: 4.147

5.  Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.

Authors:  Feng Xie; Eleanor M Pullenayegum; Shu-Chuen Li; Robert Hopkins; Julian Thumboo; Ngai-Nung Lo
Journal:  Value Health       Date:  2010-12       Impact factor: 5.725

6.  Prevalence and burden of osteoarthritis: results from a population survey in Norway.

Authors:  Margreth Grotle; Kaare Birger Hagen; Baard Natvig; Fredrik A Dahl; Tore Kristian Kvien
Journal:  J Rheumatol       Date:  2008-02-15       Impact factor: 4.666

7.  Validation of a prediction model to estimate health utilities index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip.

Authors:  Deborah Marshall; Dan Pericak; Paul Grootendorst; Katherine Gooch; Peter Faris; Cy Frank; Nicholas Bellamy; George Torrance; David Feeny
Journal:  Value Health       Date:  2008 May-Jun       Impact factor: 5.725

8.  Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Authors:  Mickaël Hiligsmann; Cyrus Cooper; Nigel Arden; Maarten Boers; Jaime C Branco; Maria Luisa Brandi; Olivier Bruyère; Francis Guillemin; Marc C Hochberg; David J Hunter; John A Kanis; Tore K Kvien; Andrea Laslop; Jean-Pierre Pelletier; Daniel Pinto; Susanne Reiter-Niesert; René Rizzoli; Lucio C Rovati; Johan L Hans Severens; Stuart Silverman; Yannis Tsouderos; Peter Tugwell; Jean-Yves Reginster
Journal:  Semin Arthritis Rheum       Date:  2013-08-29       Impact factor: 5.532

Review 9.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

10.  Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?

Authors:  Garry R Barton; Tracey H Sach; Claire Jenkinson; Anthony J Avery; Michael Doherty; Kenneth R Muir
Journal:  Health Qual Life Outcomes       Date:  2008-07-14       Impact factor: 3.186

View more
  4 in total

Review 1.  Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: a Bayesian network meta-analysis.

Authors:  Filippo Migliorini; Arne Driessen; Valentin Quack; Nadja Sippel; Brian Cooper; Yasser El Mansy; Markus Tingart; Jörg Eschweiler
Journal:  Arch Orthop Trauma Surg       Date:  2020-07-28       Impact factor: 3.067

2.  Ultrasound of knee osteoarthritis: interobserver agreement and correlation with Western Ontario and McMaster Universities Osteoarthritis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sherif Refaat El-Basyouni
Journal:  Clin Rheumatol       Date:  2015-06-20       Impact factor: 2.980

3.  Possible Involvement of Serum and Synovial Fluid Resistin in Knee Osteoarthritis: Cartilage Damage, Clinical, and Radiological Links.

Authors:  Yong-Zhou Song; Jian Guan; Hua-Jun Wang; Wei Ma; Feng Li; Fang Xu; Luo-Bin Ding; Lei Xie; Bo Liu; Kai Liu; Zhe Lv
Journal:  J Clin Lab Anal       Date:  2015-10-23       Impact factor: 2.352

Review 4.  Addressing obesity in the management of knee and hip osteoarthritis - weighing in from an economic perspective.

Authors:  Anna Flego; Michelle M Dowsey; Peter F M Choong; Marj Moodie
Journal:  BMC Musculoskelet Disord       Date:  2016-05-26       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.